Adam R. Craig, President and CEO at CTI BIOPHARMA CORP (CTIC), sold 200,266 shares at $6.00 ($1.2M) on 2022-12-29, disclosed to the SEC on 2023-01-03.
Open-market sale of $1.2M CTIC by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.00 | 13,800 | $83K | 6.9% |
| 2 | $6.00 | 12,000 | $72K | 6.0% |
| 3 | $6.01 | 700 | $4K | 0.3% |
| 4 | $6.01 | 4,400 | $26K | 2.2% |
| 5 | $6.01 | 84,683 | $509K | 42.3% |
| 6 | $6.01 | 84,683 |
| $509K |
| 42.3% |
| Total | $6.01 avg | 200,266 | $1.2M | 100% |
| Filing → |
| CTIC | SELL | 2023-01-26 | $512K | — | Filing → |
| CTIC | SELL | 2022-11-14 | $1.6M | — | Filing → |
| CTIC | SELL | 2022-09-14 | $1.6M | — | Filing → |